Literature DB >> 12410380

Increased expression of the putative axon growth-repulsive extracellular matrix molecule, keratan sulphate proteoglycan, following traumatic injury of the adult rat spinal cord.

M Krautstrunk1, F Scholtes, D Martin, J Schoenen, A B Schmitt, D Plate, W Nacimiento, J Noth, G A Brook.   

Abstract

Keratan sulphate proteoglycan (KSPG) is a developmentally regulated barrier molecule, directing axonal growth during central nervous system (CNS) formation. The possible re-expression and functional significance of KSPG in preventing axon regeneration following spinal cord injury (SCI) is poorly understood. In the present investigation, the spatio-temporal expression of KSPG was studied following experimental SCI. There was no indication of sparing of axons at the lesion epicentre following severe compression injury. By 7 days post operation (p.o.) a diffuse increase of KSPG immunoreactivity (KSPG-IR) was observed in the parenchyma surrounding the lesion. This was followed by a delayed (21-28 days p.o.) and largely heterogeneous increase of KSPG-IR in the lesion epicentre, which revealed both cellular and extracellular matrix-like distribution patterns. Although no re-growth of anterogradely labelled corticospinal axons was observed, many 200-kDa neurofilament (NF)-positive axons could be detected growing into the connective tissue scar. This phase of spontaneous axonal re-growth was closely associated with a framework of glial cells (including Schwann cells from damaged local spinal nerve roots) that had migrated into the lesion site. The spontaneous nerve fibre re-growth could be detected in both KSPG-rich and KSPG-poor territories. The present data suggest that the lesion-induced up-regulation of KSPG-IR may have contributed to the lack of corticospinal axon re-growth. However, the lack of any direct spatio-temporal correlation between the distribution of raised KSPG-IR and spontaneous NF-positive axonal regeneration suggests that at least some populations of axons can resist the putative inhibitory effects of this extracellular matrix molecule.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410380     DOI: 10.1007/s00401-002-0589-6

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  4 in total

1.  Development of a tissue-engineered composite implant for treating traumatic paraplegia in rats.

Authors:  S Rochkind; A Shahar; D Fliss; D El-Ani; L Astachov; T Hayon; M Alon; R Zamostiano; O Ayalon; I E Biton; Y Cohen; R Halperin; D Schneider; A Oron; Z Nevo
Journal:  Eur Spine J       Date:  2005-11-15       Impact factor: 3.134

2.  Benefit of chondroitinase ABC on sensory axon regeneration in a laceration model of spinal cord injury in the rat.

Authors:  Lisa B E Shields; Yi Ping Zhang; Darlene A Burke; Rebecca Gray; Christopher B Shields
Journal:  Surg Neurol       Date:  2008-06

Review 3.  Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury.

Authors:  Mark Noble; Jeannette E Davies; Margot Mayer-Pröschel; Christoph Pröschel; Stephen J A Davies
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

4.  High-throughput proteomics reveal alarmins as amplifiers of tissue pathology and inflammation after spinal cord injury.

Authors:  Athanasios Didangelos; Michele Puglia; Michaela Iberl; Candela Sanchez-Bellot; Bernd Roschitzki; Elizabeth J Bradbury
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.